Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: Exosomes derived from siRNA against GRP78 modified bone-marrow-derived mesenchymal stem cells suppress Sorafenib resistance in hepatocellular carcinoma

Fig. 6

The effect of siGRP78 modified exosomes on the metastasis of Sorafenib resistant cancer cells. a The orthotopic metastasis model showed the tumor metastasis in liver by different treatments (Control, Sorafenib, Exo-scramble siRNA + Sora and Exo-siGRP78 + Sora). b Statistic analysis showed the number of tumor nodes in liver of mice (*P < 0.05, versus Sorafenib treatment)

Back to article page